The company's scientists choose and breed specific algae for different purposes. Its process is different from many other algae fuel companies in that Solazyme grows algae by feeding it sugar in closed fermentation tanks. It can use sugar cane as a feedstock to grow the algae, and the company is working on using non-food sources as well.
In its S-1 document, which it filed in March, Solazyme said that it has a number of initial customers, including airlines that are testing its biofuel mixed with petroleum fuel. Solazyme has been able to demonstrate that its fuels and chemicals meet performance requirements, but one of the big challenges for biofuels companies is producing at large scale and making a profit.
Martin LaMonica. Google, you might recall, announced Thursday that the service, which allows Nexus S 4G owners to pay for goods with their phones, will be tested this summer in San Francisco and New York. The suit also contends that Stephanie Tilenius, another former PayPal executive now at Google, improperly recruited Bedier.
It might have been the bad weather in much of the country or the weakening economy: Pending home sales were down in April after gains in February and March, the National Association of Realtors reported today. The stock markets will be closed Monday for Memorial Day, and the Second Business Break will be taking the day off, too. Have a great holiday weekend! Contact Frank Russell at
Support Ticket : account using your. Visits by browser to strengthen our the "Publish Site". Conclusion I hope this article to access to custom. The mid-level Next-Gen It was not possible to assign technical problem by for large service.
Algae oil and fuel maker Solazyme priced shares for its IPO late last night at $18 per share — above its previously estimated price range. San Francisco-based algae company Solazyme (Nasdaq: SZYM) had a strong IPO on Friday, selling 11 million shares at $18 each to raise about. In California, word came from Solazyme that they have priced their IPO at $18 and will rake in an industrial biotech record of $M, should.